炎症性肠病中的微生物干扰:比较分析
Jianxia Ma1, Ke Wang1, Jun Wang1
1Department of Gastroenterology, Hua Dong Hospital of Fu Dan University, Shanghai, 200040, People's Republic of China.
International journal of general medicine
|April 11, 2024
概括
便微生物群分析显示,与健康个体相比,炎症性肠病 (IBD) 患者的显著差异. 特定的细菌群体在IBD亚型和活跃疾病期间发生变化,表明肠道失调.
科学领域:
- 胃肠病学 胃肠病学
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 炎症性肠病 (IBD) 包括性结肠炎 (UC) 和克罗恩病 (CD).
- 肠道微生物群失生症与IBD病原发生有关.
- 了解IBD相关的微生物变化对于诊断和治疗至关重要.
研究的目的:
- 为了研究IBD患者便微生物群的组成.
- 为了比较IBD亚型和疾病阶段的肠道微生物群特征.
- 为了识别与IBD相关的特定肠道细菌.
主要方法:
- 从41名IBD患者 (18名UC,23名CD) 和20名健康对照患者收集的便样本.
- 在便样本上进行的16S rRNA基因测序.
- 用于表征微生物群落的生物信息学分析.
主要成果:
- 与对照组相比,IBD患者的便微生物群的丰富性和多样性明显较低.
- 在IBD患者中减少了*Subdoligranulum*,*Ruminococcus*,*Anaerostipes*和*Lachnospira*的丰度.
- 在UC和CD患者中观察到不同的微生物概况,特别增加了*Streptococcus* (UC) 和*Lachnoclostridium*,*Fusobacterium* (CD).
- 在活跃IBD和缓解期之间发现了显著的变化,在活跃疾病中减少了*Roseburia*,*Coprococcus*和*Ruminiclostridium*.
结论:
- 在IBD患者中,肠道微生物不平衡是显而易见的.
- 减少 *Roseburia*, *Coprococcus* 和 *Ruminiclostridium* 的丰度可能与活跃的IBD相关.
- 这些发现突出了IBD活动的潜在微生物生物标志物.
更多相关视频
相关概念视频
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
173
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
173
01:17Chronic Bowel Disorders: Introduction
449
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
449
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
01:30Inflammatory Bowel Disease II: Crohn's Disease
227
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
227
01:17Irritable Bowel Syndrome I: Introduction
272
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
272
01:29Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127